Full-Time

Senior/Principal Scientist

Pharmaceutical Development

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Develops antibody-based medicines and technologies

AI & Machine Learning
Data & Analytics
Biotechnology

Compensation Overview

$110k - $173kAnnually

+ Equity + Bonus + RRSP contribution + Active Lifestyle Allowance + Vacation + Flexible Work Arrangements + Professional Development Opportunities + Comprehensive Health Benefits

Senior

Vancouver, BC, Canada

Requirements
  • Ph.D. and 10+ years of experience, M.Sc. or B.Sc. and 15+ years of experience
  • Proven experience leading a team
  • In-depth knowledge of formulation, drug product and in-use stability development with monoclonal antibodies or related biotherapeutic antibodies
  • Expertise in biophysical or biochemical characterization of proteins and degradation pathways
  • Experience authoring drug product sections of regulatory filings such as INDs, IMPDs, etc.
  • Experience with late phase formulation and drug product development, authoring BLAs would be advantageous
  • Experience with lab automation
  • Strong written and verbal communication skills
  • Familiarity with electronic lab notebooks (Ex. Benchling) and experimental data capture
Responsibilities
  • Providing strategic, technical and tactical leadership for the Formulation Development team
  • Developing antibody formulation and drug product process development
  • Contributing to multiple concurrent projects
  • Representing the formulation function on internal and external CMC teams
  • Providing leadership on interpretation of analytical results
  • Authoring and reviewing technical reports and regulatory submissions
  • Building and managing partnerships with various departments
  • Providing support, mentorship, and training to junior staff

AbCellera distinguishes itself as an exemplary workplace within the biotechnology sector by expertly merging advanced technology and data science with an integrated team of experts. This strategic amalgamation not only speeds up the development of antibody-based medicines but also fosters an environment that is at the cutting edge of therapeutic innovation. By working here, one can directly contribute to solving complex challenges in drug development, benefiting from a collaborative culture that emphasizes efficiency and breakthroughs in healthcare solutions.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

3%

1 year growth

11%

2 year growth

73%